UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: March 28, 2024
Accession Number: 0001193125-24-075257
Submission Type: POS AM
CIK: 0001042074
Company Name: CymaBay Therapeutics, Inc.
File Number: 333-229082